Cronos Group and Geocann Work Together to Use VESIsorb® Delivery Technology for Quicker Absorption
In collaboration with Geocann, Cronos Group Inc. is happy to announce the release of the first of what is anticipated to be several products that will make use of the cutting-edge VESIsorb® delivery system. Faster ... [Read]
Agrify Enters the Lucrative New Zealand Cannabis Market With End-To-End Solutions for Cultivation and Extraction Through Sales and SAAS Licensing Agreement With Ora Pharm.
AgrifyTM Corporation, the most cutting-edge supplier of advanced cultivation and extraction solutions for the cannabis industry, announced it has signed a legally binding agreement (the “Agreement”) to provide Ora Pharm, a Waikato, New Zealand-based health ... [Read]
Amryt to Pursue Formal Dispute Resolution for Oleogel-S10 (Filsuvez®) NDA
Amryt (Nasdaq: AMYT), a multinational, commercial-stage biopharmaceutical company with a focus on acquiring, developing, and commercializing novel treatments for rare diseases, today announced its intention to submit a Formal Dispute Resolution Request (FDRR) for its ... [Read]
Eton Pharmaceuticals Sells Hospital Supplies to Dr. Reddy’s for up to $50M
Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today declared that it had agreed to sell its hospital goods to Dr. Reddy’s Laboratories SA, a ... [Read]
Splash Beverage Group Enters into Agreement to Purchase 80% of Pulpoloco Sangria
Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of well-known beverage brands, announced today that it has signed a contract to purchase 80 percent of Pulpoloco Sangria. As a ... [Read]
Evaxion Biotech Broadens EVX-03 DNA Vaccine Project Into Non-Small Cell Lung Cancer.
Evaxion Biotech A/S (NASDAQ: EVAX) a clinical-stage biotechnology company focused on the creation of AI-driven immunotherapies, announced today that it has chosen EVX-03 as the product candidate within its DNA technology platform to target a ... [Read]
Optimi Health Requests for Authorization to Manufacture MDMA, Other Synthetic Psychedelics
Optimi Health Corp, a native Canadian business that creates natural, scalable, and affordable mushroom formulations for transformational human experiences, has made a health request to Canada for an amendment to the Controlled Substances Dealer’s Licence. ... [Read]
Massage Envy Enhances Massage and Skin Care Portfolio With CBD Offerings From Charlotte’s Web, The World’s Most Reliable Hemp Extract™ (CWBHF)
Massage Envy, the nation’s No. 1 provider of massage in the U.S. overall across its franchise network and a national leader in skincare, together with Charlotte’s Web Inc., the market leader in creating next-generation, hemp-derived ... [Read]
TAAT Global Alternatives Has Appointed Michael Saxon as CEO
TAAT Global Alternatives Inc. (CSE:TAAT) recently announced the appointment of Michael Saxon as Chief Executive Officer. Saxon will also be joining as a member of its Board of Directors. Michael Saxon is a 20-year global ... [Read]
FPX Nickel Signs a Development Memorandum of Agreement with Indigenous Partner Binche Whut’en
FPX Nickel Corp. (TSXV:FPX) is pleased to announce that it has signed a new Development Memorandum of Agreement (“MoA”) with the Binche Keyoh Bu Society (the “Binche Society”), which represents the Keyoh families within the ... [Read]